David W. Osborne

Insider Reports History

Entity
Individual
Signature
/s/ Scott Burrows, as Attorney-in-Fact for David W. Osborne, Ph.D.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David W. Osborne:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Arcutis Biotherapeutics, Inc. Chief Technical Officer Common Stock 269K $952K $3.54 Mar 6, 2023 Direct
Arcutis Biotherapeutics, Inc. Chief Technical Officer Stock Option (Right to Buy) 39.5K Mar 2, 2023 Direct

Insider Reports Filed by David W. Osborne

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ARQT Arcutis Biotherapeutics, Inc. Mar 6, 2023 1 -$10.5K 4 Mar 8, 2023 Chief Technical Officer
ARQT Arcutis Biotherapeutics, Inc. Mar 2, 2023 2 $0 4 Mar 6, 2023 Chief Technical Officer
ARQT Arcutis Biotherapeutics, Inc. Feb 28, 2023 3 -$32K 4 Mar 2, 2023 Chief Technical Officer
ARQT Arcutis Biotherapeutics, Inc. Jul 8, 2022 1 -$55.8K 4 Jul 12, 2022 Chief Technical Officer
ARQT Arcutis Biotherapeutics, Inc. Apr 21, 2022 1 -$44.9K 4 Apr 21, 2022 Chief Technical Officer
ARQT Arcutis Biotherapeutics, Inc. Mar 3, 2022 4 -$14.4K 4 Mar 7, 2022 Chief Technical Officer
ARQT Arcutis Biotherapeutics, Inc. Mar 1, 2022 1 -$13.8K 4 Mar 3, 2022 Chief Technical Officer